Market tracking is not only exciting but has recently become a requirement under the Medical Device regulations (MDR) of the EU. Join us in learning what steps are necessary to complete the post-market clinical follow-up!
Collaboration Funding Innovation Press Release Regulatory
Revolutionising biomedical data sharing and AI-driven healthcare solutions
Liestal, Switzerland, September 2023 – HEMEX, a bench-to-market clinical Contract Research Organization (CRO) announces the [...]
Continue reading
Investment Press Release
hemotune makes a significant step forward: advancing into clinical trials after completing CHF 14 million Series B2 round
Liestal, Switzerland, September 2023 – HEMEX, a bench-to-market clinical Contract Research Organization (CRO) announces the [...]
Continue reading
Diversity Hemex Team
We welcome David to the team!
HEMEX contribution for preparing tomorrow's leaders!
Continue reading
Investment Press Release
Driving the future of non-surgical endometriosis diagnosis: Hera Biotech acquires Scailyte’s endometriosis diagnostic assets
Liestal, Switzerland, September 2023 – HEMEX, a bench-to-market clinical Contract Research Organization (CRO) announces the [...]
Continue reading
Hemex Team
Graphic Design Internship at HEMEX
Noémie is a student at FMS Muttenz. She completed a two-week internship at HEMEX focusing [...]
Continue readingCollaboration, Press Release
Resistell AG announces completion of clinical pilot Performance Evaluation Study
We’re delighted to announce that our portfolio startup Resistell AG has completed the pilot phase of its clinical Performance Evaluation
Study (PES) with 100% accuracy and at least 7 hours shorter time-to-result (TTR) compared to gold standard methods.
Welcome to the last article of HEMEX’s diversity series! Today we want to introduce you to our newest team member Manuela. Manuela grew up in Basel, Switzerland, and is currently studying medicine at the University of Basel. Curious about what brought her to HEMEX? Let’s keep reading and find out!
The Austrian biotech company is developing endolysins and phages as therapeutics, focusing on persistent bacterial infections that cannot be targeted with broad-spectrum antibiotics. This acquisition is a big step for the AMR crisis and the formerly Phagomed team. At HEMEX, we wanted to congratulate them on their fantastic job!
December 3rd is the international day of people with disabilities. Therefore, on this day, we’d like to raise awareness on the dignity and well-being of persons with disabilities while fostering a deeper understanding of the topic.
Continuing with HEMEX’s diversity series, we want to introduce you to our new team members Leonardo and Luana. Leonardo grew up in Milan, Italy, and Luana in the canton of Basel-Land, Switzerland. Both are dedicated to improving our society’s health system, and we are delighted with these new fresh ideas in our team! Do you want to know what brought them to HEMEX? Keep reading to find out.
HEMEX is pleased to announce the successful completion of another fundraising round. Following an oversubscribed first closing in February, our second closing of the Series C increased the round to CHF 7.1 million.
Following up on our diversity series, meet today Aurelia and Nycole. They are two outstanding young spirited women. At HEMEX, we are thrilled to have them on our team because they strengthen our work. Do you want to know a little more about their lives and how they ended up at HEMEX? Keep reading!
Today, we continue with our diversity series. In this article, please meet Andrea and Lucie. Andrea is our Clinical Research Associate from New Zealand, and Lucie is our Marketing & Sales Assistant from Czech Republic. Would you like to learn more about them?
October is known as the worldwide awareness month of breast cancer. Previously, we have talked about how early detection and personalized cancer treatment plans are key factors in breast cancer control. The purpose of this year’s message is to focus on what can be done before? We’ll talk about some preventive measures which individuals can follow to take care of their well-being.